Badge
11,371 badges added since 01 January 2025
ISO 27001 Certificate
SOC 1 Type I Certificate
SOC 2 Type II Certificate
PCI DSS
HIPAA
RGPD
Internal validation & live display
Multiple badges & continuous verification
Faster underwriting decisions
ISOSOC2 Type 1SOC2 Type 2PCI DSSHIPAAGDPR

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

Parexel A.I CyberSecurity Scoring

Parexel

Company Details

Linkedin ID:

parexel

Employees number:

20,434

Number of followers:

831,540

NAICS:

3254

Industry Type:

Pharmaceutical Manufacturing

Homepage:

parexel.com

IP Addresses:

0

Company ID:

PAR_1325249

Scan Status:

In-progress

AI scoreParexel Risk Score (AI oriented)

Between 750 and 799

https://images.rankiteo.com/companyimages/parexel.jpeg
Parexel Pharmaceutical Manufacturing
Updated:
  • Powered by our proprietary A.I cyber incident model
  • Insurance preferes TPRM score to calculate premium
globalscoreParexel Global Score (TPRM)

XXXX

https://images.rankiteo.com/companyimages/parexel.jpeg
Parexel Pharmaceutical Manufacturing
  • Instant access to detailed risk factors
  • Benchmark vs. industry & size peers
  • Vulnerabilities
  • Findings

Parexel Company CyberSecurity News & History

Past Incidents
1
Attack Types
1
EntityTypeSeverityImpactSeenBlog DetailsSupply Chain SourceIncident DetailsView
ParexelVulnerability25110/2025OracleOracle
Rankiteo Explanation :
Attack without any consequences

Description: Parexel Reports Data Breach Impacting Sensitive Employee Information Parexel, a global clinical research organization, disclosed a data breach affecting sensitive personal information stored in its Oracle OCI E-Business Suite (Oracle EBS) environment. On October 4, 2025, the company detected suspicious activity within the system, prompting an investigation. The breach, confirmed through forensic analysis, revealed that an unauthorized third party accessed employee-related data. Exposed information may include names, Social Security numbers, dates of birth, financial account numbers, payment card details (excluding CVVs), and national ID numbers, though the exact data varies by individual. On December 17, 2025, Parexel began notifying affected individuals via mail, detailing the compromised information and offering 24 months of complimentary credit monitoring services. The breach notice was filed with the Attorney General of Massachusetts, where impacted residents were among the first to be informed. The full scope of affected individuals and additional details remain under review.

Oracle and Parexel: Parexel Data Breach Investigation
Vulnerability
Severity: 25
Impact: 1
Seen: 10/2025
Blog:
Supply Chain Source: OracleOracle
Rankiteo Explanation
Attack without any consequences

Description: Parexel Reports Data Breach Impacting Sensitive Employee Information Parexel, a global clinical research organization, disclosed a data breach affecting sensitive personal information stored in its Oracle OCI E-Business Suite (Oracle EBS) environment. On October 4, 2025, the company detected suspicious activity within the system, prompting an investigation. The breach, confirmed through forensic analysis, revealed that an unauthorized third party accessed employee-related data. Exposed information may include names, Social Security numbers, dates of birth, financial account numbers, payment card details (excluding CVVs), and national ID numbers, though the exact data varies by individual. On December 17, 2025, Parexel began notifying affected individuals via mail, detailing the compromised information and offering 24 months of complimentary credit monitoring services. The breach notice was filed with the Attorney General of Massachusetts, where impacted residents were among the first to be informed. The full scope of affected individuals and additional details remain under review.

Ailogo

Parexel Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

🔒
Incident Predictions locked
Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

🔒
A.I. Risk Score Predictions locked
Access Monitoring Plan
statics

Underwriter Stats for Parexel

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Parexel in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Parexel in 2026.

Incident Types Parexel vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Parexel in 2026.

Incident History — Parexel (X = Date, Y = Severity)

Parexel cyber incidents detection timeline including parent company and subsidiaries

Parexel Company Subsidiaries

SubsidiaryImage

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

Loading...
similarCompanies

Parexel Similar Companies

Fundada há mais de 60 anos e com capital 100% nacional, a EMS é a líder do mercado farmacêutico brasileiro há 19 anos consecutivos, pertencente ao Grupo NC, um dos maiores conglomerados brasileiros. A empresa ocupa também a liderança no segmento de genéricos desde 2013 (IQVIA 2019) e está entre os

Merck

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccine

AUROBINDO PHARMA LTD

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active

AbbVie

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye ca

Lupin

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Tr

Alembic Pharmaceuticals Limited

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol

Eli Lilly and Company

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and

MENARINI Group

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic

Alkem Laboratories Ltd.

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient,

newsone

Parexel CyberSecurity News

December 18, 2025 08:00 AM
Parexel Data Breach Claims Investigated by Lynch Carpenter

PITTSBURGH, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Parexel International, LLC (“Parexel”), a clinical research organization based in North...

August 20, 2025 07:00 AM
Inotiv Data Breach Disrupts Operations; Attorneys Investigating

A class action is being considered over the Inotiv data breach. Learn about the incident and how potential victims may be able to recover...

July 14, 2025 07:00 AM
Dordt University Data Breach Lawsuit Investigation

Did Dordt send you a data breach letter? If so, your personal info may have been exposed, and you could now help start a class action.

May 16, 2025 07:00 AM
AI Can’t Fix Clinical Trials Without The Right People, New Parexel Report

The potential of artificial intelligence in pharmaceutical research is intriguing. AI software is making its way into clinical research...

December 16, 2024 08:00 AM
Exabeam Appoints Mike Byron as Chief Financial Officer

Exabeam, a global cybersecurity leader that delivers AI-driven security operations, today announced the appointment of Mike Byron as Chief...

November 08, 2024 03:28 AM
Cybercriminals Leak ExecuPharm Internal Documents After Ransomware Attack

A successful ransomware attack was deployed on March 13 against ExecuPharm, a subsidiary of the US Biopharmaceutical giant Parexel.

October 03, 2024 07:00 AM
American Water Data Breach Lawsuit Investigation

If you are a customer of the company, you may be able to start a class action to collect money for any harm resulting from the cybersecurity...

April 03, 2017 07:00 AM
PAREXEL Unveils Patient Sensor Solution To Transform Clinical Trial Data Collection

PAREXEL has unveiled its new patient sensor solution that securely captures, transmits, stores and visualizes study subject data in clinical...

faq

Frequently Asked Questions

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.

Parexel CyberSecurity History Information

Official Website of Parexel

The official website of Parexel is http://www.parexel.com.

Parexel’s AI-Generated Cybersecurity Score

According to Rankiteo, Parexel’s AI-generated cybersecurity score is 794, reflecting their Fair security posture.

How many security badges does Parexel’ have ?

According to Rankiteo, Parexel currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Parexel been affected by any supply chain cyber incidents ?

According to Rankiteo, Parexel has been affected by a supply chain cyber incident involving Oracle, with the incident ID ORAPAR1766015901.

Does Parexel have SOC 2 Type 1 certification ?

According to Rankiteo, Parexel is not certified under SOC 2 Type 1.

Does Parexel have SOC 2 Type 2 certification ?

According to Rankiteo, Parexel does not hold a SOC 2 Type 2 certification.

Does Parexel comply with GDPR ?

According to Rankiteo, Parexel is not listed as GDPR compliant.

Does Parexel have PCI DSS certification ?

According to Rankiteo, Parexel does not currently maintain PCI DSS compliance.

Does Parexel comply with HIPAA ?

According to Rankiteo, Parexel is not compliant with HIPAA regulations.

Does Parexel have ISO 27001 certification ?

According to Rankiteo,Parexel is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Industry Classification of Parexel

Parexel operates primarily in the Pharmaceutical Manufacturing industry.

Number of Employees at Parexel

Parexel employs approximately 20,434 people worldwide.

Subsidiaries Owned by Parexel

Parexel presently has no subsidiaries across any sectors.

Parexel’s LinkedIn Followers

Parexel’s official LinkedIn profile has approximately 831,540 followers.

NAICS Classification of Parexel

Parexel is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Parexel’s Presence on Crunchbase

No, Parexel does not have a profile on Crunchbase.

Parexel’s Presence on LinkedIn

Yes, Parexel maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/parexel.

Cybersecurity Incidents Involving Parexel

As of January 22, 2026, Rankiteo reports that Parexel has experienced 1 cybersecurity incidents.

Number of Peer and Competitor Companies

Parexel has an estimated 5,507 peer or competitor companies worldwide.

What types of cybersecurity incidents have occurred at Parexel ?

Incident Types: The types of cybersecurity incidents that have occurred include Vulnerability.

How does Parexel detect and respond to cybersecurity incidents ?

Detection and Response: The company detects and responds to cybersecurity incidents through an communication strategy with data breach notification letters mailed to impacted individuals..

Incident Details

Can you provide details on each incident ?

Incident : Data Breach

Title: Parexel Data Breach Involving Sensitive Personal Information

Description: Parexel reported a data breach where sensitive personal identifiable information in its Oracle OCI E-Business Suite environment may have been compromised. An unauthorized third party accessed the data, leading to the exposure of personal and financial information of employees.

Date Detected: 2025-10-04

Date Publicly Disclosed: 2025-12-17

Type: Data Breach

Threat Actor: Unauthorized third party

What are the most common types of attacks the company has faced ?

Common Attack Types: The most common types of attacks the company has faced is Vulnerability.

Impact of the Incidents

What was the impact of each incident ?

Incident : Data Breach ORAPAR1766015901

Data Compromised: Sensitive personal identifiable information

Systems Affected: Oracle OCI E-Business Suite (Oracle EBS)

Identity Theft Risk: High

Payment Information Risk: High

What types of data are most commonly compromised in incidents ?

Commonly Compromised Data Types: The types of data most commonly compromised in incidents are Name, Social Security Number, Date Of Birth, Financial Account Number, Payment Card Number (Without Cvv), National Id Number and .

Which entities were affected by each incident ?

Incident : Data Breach ORAPAR1766015901

Entity Name: Parexel

Entity Type: Company

Industry: Clinical Research, Pharmaceutical

Customers Affected: Employees

Response to the Incidents

What measures were taken in response to each incident ?

Incident : Data Breach ORAPAR1766015901

Communication Strategy: Data breach notification letters mailed to impacted individuals

Data Breach Information

What type of data was compromised in each breach ?

Incident : Data Breach ORAPAR1766015901

Type of Data Compromised: Name, Social security number, Date of birth, Financial account number, Payment card number (without cvv), National id number

Sensitivity of Data: High

Personally Identifiable Information: Yes

Regulatory Compliance

Were there any regulatory violations and fines imposed for each incident ?

Incident : Data Breach ORAPAR1766015901

Regulatory Notifications: Reported to the Attorney General of the Commonwealth of Massachusetts

References

Where can I find more information about each incident ?

Incident : Data Breach ORAPAR1766015901

Source: Attorney General of the Commonwealth of Massachusetts

Where can stakeholders find additional resources on cybersecurity best practices ?

Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at and Source: Attorney General of the Commonwealth of Massachusetts.

Investigation Status

What is the current status of the investigation for each incident ?

Incident : Data Breach ORAPAR1766015901

Investigation Status: Completed

How does the company communicate the status of incident investigations to stakeholders ?

Communication of Investigation Status: The company communicates the status of incident investigations to stakeholders through Data breach notification letters mailed to impacted individuals.

Stakeholder and Customer Advisories

Were there any advisories issued to stakeholders or customers for each incident ?

Incident : Data Breach ORAPAR1766015901

Customer Advisories: 24 months of complimentary credit monitoring services provided to affected individuals

What advisories does the company provide to stakeholders and customers following an incident ?

Advisories Provided: The company provides the following advisories to stakeholders and customers following an incident: was 24 months of complimentary credit monitoring services provided to affected individuals.

Additional Questions

General Information

Who was the attacking group in the last incident ?

Last Attacking Group: The attacking group in the last incident was an Unauthorized third party.

Incident Details

What was the most recent incident detected ?

Most Recent Incident Detected: The most recent incident detected was on 2025-10-04.

What was the most recent incident publicly disclosed ?

Most Recent Incident Publicly Disclosed: The most recent incident publicly disclosed was on 2025-12-17.

Impact of the Incidents

What was the most significant data compromised in an incident ?

Most Significant Data Compromised: The most significant data compromised in an incident was Sensitive personal identifiable information.

Data Breach Information

What was the most sensitive data compromised in a breach ?

Most Sensitive Data Compromised: The most sensitive data compromised in a breach was Sensitive personal identifiable information.

References

What is the most recent source of information about an incident ?

Most Recent Source: The most recent source of information about an incident is Attorney General of the Commonwealth of Massachusetts.

Investigation Status

What is the current status of the most recent investigation ?

Current Status of Most Recent Investigation: The current status of the most recent investigation is Completed.

Stakeholder and Customer Advisories

What was the most recent customer advisory issued ?

Most Recent Customer Advisory: The most recent customer advisory issued was an 24 months of complimentary credit monitoring services provided to affected individuals.

cve

Latest Global CVEs (Not Company-Specific)

Description

Backstage is an open framework for building developer portals, and @backstage/backend-defaults provides the default implementations and setup for a standard Backstage backend app. Prior to versions 0.12.2, 0.13.2, 0.14.1, and 0.15.0, the `FetchUrlReader` component, used by the catalog and other plugins to fetch content from URLs, followed HTTP redirects automatically. This allowed an attacker who controls a host listed in `backend.reading.allow` to redirect requests to internal or sensitive URLs that are not on the allowlist, bypassing the URL allowlist security control. This is a Server-Side Request Forgery (SSRF) vulnerability that could allow access to internal resources, but it does not allow attackers to include additional request headers. This vulnerability is fixed in `@backstage/backend-defaults` version 0.12.2, 0.13.2, 0.14.1, and 0.15.0. Users should upgrade to this version or later. Some workarounds are available. Restrict `backend.reading.allow` to only trusted hosts that you control and that do not issue redirects, ensure allowed hosts do not have open redirect vulnerabilities, and/or use network-level controls to block access from Backstage to sensitive internal endpoints.

Risk Information
cvss3
Base: 3.5
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:N/A:N
Description

Backstage is an open framework for building developer portals, and @backstage/cli-common provides config loading functionality used by the backend and command line interface of Backstage. Prior to version 0.1.17, the `resolveSafeChildPath` utility function in `@backstage/backend-plugin-api`, which is used to prevent path traversal attacks, failed to properly validate symlink chains and dangling symlinks. An attacker could bypass the path validation via symlink chains (creating `link1 → link2 → /outside` where intermediate symlinks eventually resolve outside the allowed directory) and dangling symlinks (creating symlinks pointing to non-existent paths outside the base directory, which would later be created during file operations). This function is used by Scaffolder actions and other backend components to ensure file operations stay within designated directories. This vulnerability is fixed in `@backstage/backend-plugin-api` version 0.1.17. Users should upgrade to this version or later. Some workarounds are available. Run Backstage in a containerized environment with limited filesystem access and/or restrict template creation to trusted users.

Risk Information
cvss3
Base: 6.3
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:N/A:N
Description

Backstage is an open framework for building developer portals. Multiple Scaffolder actions and archive extraction utilities were vulnerable to symlink-based path traversal attacks. An attacker with access to create and execute Scaffolder templates could exploit symlinks to read arbitrary files via the `debug:log` action by creating a symlink pointing to sensitive files (e.g., `/etc/passwd`, configuration files, secrets); delete arbitrary files via the `fs:delete` action by creating symlinks pointing outside the workspace, and write files outside the workspace via archive extraction (tar/zip) containing malicious symlinks. This affects any Backstage deployment where users can create or execute Scaffolder templates. This vulnerability is fixed in `@backstage/backend-defaults` versions 0.12.2, 0.13.2, 0.14.1, and 0.15.0; `@backstage/plugin-scaffolder-backend` versions 2.2.2, 3.0.2, and 3.1.1; and `@backstage/plugin-scaffolder-node` versions 0.11.2 and 0.12.3. Users should upgrade to these versions or later. Some workarounds are available. Follow the recommendation in the Backstage Threat Model to limit access to creating and updating templates, restrict who can create and execute Scaffolder templates using the permissions framework, audit existing templates for symlink usage, and/or run Backstage in a containerized environment with limited filesystem access.

Risk Information
cvss3
Base: 7.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:N/A:L
Description

FastAPI Api Key provides a backend-agnostic library that provides an API key system. Version 1.1.0 has a timing side-channel vulnerability in verify_key(). The method applied a random delay only on verification failures, allowing an attacker to statistically distinguish valid from invalid API keys by measuring response latencies. With enough repeated requests, an adversary could infer whether a key_id corresponds to a valid key, potentially accelerating brute-force or enumeration attacks. All users relying on verify_key() for API key authentication prior to the fix are affected. Users should upgrade to version 1.1.0 to receive a patch. The patch applies a uniform random delay (min_delay to max_delay) to all responses regardless of outcome, eliminating the timing correlation. Some workarounds are available. Add an application-level fixed delay or random jitter to all authentication responses (success and failure) before the fix is applied and/or use rate limiting to reduce the feasibility of statistical timing attacks.

Risk Information
cvss3
Base: 3.7
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N
Description

The Flux Operator is a Kubernetes CRD controller that manages the lifecycle of CNCF Flux CD and the ControlPlane enterprise distribution. Starting in version 0.36.0 and prior to version 0.40.0, a privilege escalation vulnerability exists in the Flux Operator Web UI authentication code that allows an attacker to bypass Kubernetes RBAC impersonation and execute API requests with the operator's service account privileges. In order to be vulnerable, cluster admins must configure the Flux Operator with an OIDC provider that issues tokens lacking the expected claims (e.g., `email`, `groups`), or configure custom CEL expressions that can evaluate to empty values. After OIDC token claims are processed through CEL expressions, there is no validation that the resulting `username` and `groups` values are non-empty. When both values are empty, the Kubernetes client-go library does not add impersonation headers to API requests, causing them to be executed with the flux-operator service account's credentials instead of the authenticated user's limited permissions. This can result in privilege escalation, data exposure, and/or information disclosure. Version 0.40.0 patches the issue.

Risk Information
cvss3
Base: 5.3
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:N/A:N

Access Data Using Our API

SubsidiaryImage

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=parexel' -H 'apikey: YOUR_API_KEY_HERE'

What Do We Measure ?

revertimgrevertimgrevertimgrevertimg
Incident
revertimgrevertimgrevertimgrevertimg
Finding
revertimgrevertimgrevertimgrevertimg
Grade
revertimgrevertimgrevertimgrevertimg
Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network Security

Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)

Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)

Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat Intelligence

Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Top LeftTop RightBottom LeftBottom Right
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
Users Love Us Badge